Literature DB >> 17214262

Office-based and microlaryngeal applications of a fiber-based thulium laser.

Steven M Zeitels1, James A Burns, Lee M Akst, Robert E Hillman, Matthew S Broadhurst, R Rox Anderson.   

Abstract

OBJECTIVES: The carbon dioxide (CO2) laser is the premier dissecting instrument for hemostatic cutting and ablation during endolaryngeal surgery. However, microlaryngeal tangential dissection and office-based photoablation have been limited by the lack of a fiber-based delivery system. To address this limitation, a new laser was designed, which is a diode-pumped solid-state laser with a thulium-doped yttrium-aluminum-garnet laser rod. It produces a continuous-wave beam with a wavelength of 2013 nm and a target chromophore of water. This new laser functions similarly to a CO2 laser with the benefit of being delivered through a small glass fiber (0.365 to 0.550 mm).
METHODS: A prospective pilot trial was done in 74 cases to explore applications of the new thulium laser. Thirty-two procedures were done with the laser used as an ablating instrument and topical anesthesia through a flexible laryngoscope (papillomatosis, 20; microinvasive carcinoma, 6; benign supraglottic lesions, 3; edema, 2; granuloma, (1). Forty-two procedures were done with the laser used as a cutting or ablating instrument for microlaryngeal dissection and general anesthesia. These included 27 partial laryngeal resections (supraglottis, 15; glottis, 10; subglottis, (2) and 8 posterior glottic laryngoplasties. The laser was also used as an ablative instrument during microlaryngoscopy in 7 cases.
RESULTS: The thulium laser was used effectively in all cases, under both local and general anesthesia. In microlaryngeal dissection, electrocautery was not needed to control bleeding, even during cutting in the highly vascular paraglottic space. No complications related to the use of the thulium laser were experienced in any case.
CONCLUSIONS: Because of the fiber-based delivery system, the 2013-nm continuous-wave thulium laser shows substantial promise for tangential dissection during microlaryngoscopy and soft tissue photoablation during office-based flexible laryngoscopy. Hemostasis was judged to be superior to experiences with the CO2 laser. In this pilot study, performing en bloc laryngeal cancer resection procedures was facilitated by use of the thulium laser.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17214262     DOI: 10.1177/000348940611501206

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  5 in total

1.  A 2-microm continuous-wave laser system for safe and high-precision dissection during NOTES procedures.

Authors:  Xavier Dray; Gianfranco Donatelli; Devi Mukkai Krishnamurty; Elena Dubcenco; Ronald J Wroblewski; Lia Assumpcao; Samuel A Giday; Jonathan M Buscaglia; Eun J Shin; Priscilla Magno; Laurie J Pipitone; Michael R Marohn; Sergey V Kantsevoy; Anthony N Kalloo
Journal:  Dig Dis Sci       Date:  2010-09       Impact factor: 3.199

2.  Comparative analysis of resection tools suited for transoral robot-assisted surgery.

Authors:  Thomas K Hoffmann; Patrick J Schuler; Agnes Bankfalvi; Jens Greve; Lukas Heusgen; Stephan Lang; Stefan Mattheis
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-07-12       Impact factor: 2.503

Review 3.  Use of lasers in laryngeal surgery.

Authors:  Yan Yan; Aleksandra E Olszewski; Matthew R Hoffman; Peiyun Zhuang; Charles N Ford; Seth H Dailey; Jack J Jiang
Journal:  J Voice       Date:  2009-05-31       Impact factor: 2.009

Review 4.  Novel Energy Devices in Head and Neck Robotic Surgery - A Narrative Review.

Authors:  Talisa Ross; Neil S Tolley; Zaid Awad
Journal:  Robot Surg       Date:  2020-04-23

5.  Comparative study between thulium laser and cold knife visual urethrotomy for treatment of short bulbomembranous urethral stricture.

Authors:  Mohamed Rehan; Esam A Elnady; Saed Khater; Ahmed Fawzi Arafat Elsayed; Ahmed M Abdel Gawad; Mohamed Abdel Hafeez Aly Freeg; Alaa R Mahmoud
Journal:  Medicine (Baltimore)       Date:  2022-09-02       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.